Pegylated Liposomal Doxorubicin-Induced Acute Transient Encephalopathy in a Patient with Breast Cancer: A Case Report

Publisher： Karger

E-ISSN： 1662-6575|7|1|228-232

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.1, 2014-03, pp. : 228-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegylated Liposomal Doxorubicin in Combination with Hyperthermia for Treatment of Skin Metastases of Breast Carcinoma: A Case Report

By  

Oncology Research and Treatment, Vol. 24, Iss. 2, 2001-05 ,pp. : 166-168

Karger

Access to resources Recommend Favorite

Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer

By  

Oncology, Vol. 76, Iss. 4, 2009-03 ,pp. : 275-285

Karger

Access to resources Recommend Favorite

Liposomal doxorubicin in breast cancer

By Shehata M   Mukherjee A   Sharma R   Chan S  

Women's Health, Vol. 3, Iss. 5, 2007-09 ,pp. : 557-569

Future Medicine

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin with Vinorelbine in Metastatic Breast Carcinoma

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 23-30

Karger

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin (Caelyx®) in Metastatic Breast Cancer: A Community-Based Observation Study

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 147-151

Karger

Access to resources Recommend Favorite